Sanofi said European regulators have accepted its marketing application for a quadrivalent version of its Vaxigrip flu vaccine. The new vaccine is designed to fight the four strains of flu virus anticipated in the coming season. Sanofi plans to apply for marketing approval in all countries where the three-strain Vaxigrip is currently marketed.

Full Story:

Related Summaries